Is Erasca Inc (ERAS) a risky stock?
As of July 27, 2026, Clavix grades Erasca Inc (ERAS) D for risk, a composite score of 41 out of 100 on an A+ to F scale, which puts ERAS in the "elevated risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
ERAS price, last 3 months
ERAS's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind ERAS's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how ERAS scores on each, as of July 27, 2026.
What's moving ERAS's risk right now
Company-specific signals Clavix flags behind ERAS's current grade, drawn from recent news and filings as of July 27, 2026.
Multiple law firms are notifying Erasca investors about a securities class action lawsuit. Investors who suffered losses have until August 10, 2026 to seek lead plaintiff status, and the lawsuit could mean legal costs and reputational damage for Erasca.
Recent ERAS news
The latest headlines Clavix ingested for Erasca Inc, newest first. These feed the news-sentiment dimension of ERAS's grade.
-
Law firm Bronstein, Gewirtz & Grossman LLC has filed a class action against Erasca, Inc. (ERAS) alleging securities fraud violations and urging investors to seek recovery, with a lead plaintiff deadline of August 10, 2026.
-
Law firm Kaplan Fox Kilsheimer LLP has issued a reminder to Erasca, Inc. (ERAS) investors about an upcoming lead plaintiff deadline of August 10, 2026, suggesting an active securities class action lawsuit. The full details of the body text were not provided.
What a D grade means
On the Clavix A+ to F scale, ERAS's composite of 41 falls in the D band (35–49), read as "elevated risk." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell ERAS or any security. Grades are risk indicators, not predictions of return. Data may be delayed.